Skip to content

Relapsing-remitting Multiple Sclerosis

Relapsing-remitting multiple sclerosis is a form of multiple sclerosis marked by attacks, called relapses, followed by recovery. It is one pattern used to describe how the condition behaves over time.

Aubagio

Teriflunomide

14mg

Teriflunomide tablets for relapsing remitting multiple sclerosis. It reduces the overactive immune response that damages nerve fibres in the brain and spinal cord.

From$205.67/ tabletView

Aubagio

Teriflunomide

14mg

Teriflunomide tablets for relapsing remitting multiple sclerosis. It reduces the overactive immune response that damages nerve fibres in the brain and spinal cord.

From$205.67/ tabletView

Key points

  • Symptoms: Changes to vision, sensation, movement or balance can occur during a relapse and differ between people.
  • Other patterns: Multiple sclerosis may also be secondary progressive or primary progressive, classified by disease activity and progression.
  • Uncertainty: No accurate method can predict an individual’s future course, which can vary greatly from person to person.

Medicines listed for Relapsing-remitting Multiple Sclerosis

The listed products contain Teriflunomide and are described as 14 mg tablets. Teriflunomide is a disease-modifying medicine used for relapsing-remitting multiple sclerosis, including periods of relapsing and remitting.

Further reading